Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. 

Biotechnology

CIRCULOGENE

Mike Mullen

Patrick Shea

Christy Lee

Paul R. Walker

Scott Grissett

Eric Thompson

J. Kevin Day

Lou Apicella

Travis Wold

Jonice Vanterpool Johnson

Anthony L. Schmidt

Chen-Hsiung Yeh

Commercial and Business Development Team

Leadership Team

Laboratory Operations Team

Clinical and Medical Team

Finance and Legal Team

��

Teams at CIRCULOGENE

Commercial and Business Development Team

Leadership Team

Laboratory Operations Team

Clinical and Medical Team

Finance and Legal Team

��������

Teams at CIRCULOGENE

Commercial and Business Development Team

Leadership Team

Laboratory Operations Team

Clinical and Medical Team

Finance and Legal Team

��